Our results demonstrate that apigenin and specific flavonoids form a potent bond with the CDK6 protein (but less potent than ribociclib, a CDK6 inhibitor), presenting a potential benefit when combined with ribociclib to reduce neutropenia and gastrointestinal toxicity induced by ribociclib [68]. Here, CDK6 is linked to neutropenia.